Home/Filings/4/0001415889-25-001016
4//SEC Filing

Gravier Pierre 4

Accession 0001415889-25-001016

CIK 0001070081other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 5:20 PM ET

Size

7.7 KB

Accession

0001415889-25-001016

Insider Transaction Report

Form 4
Period: 2025-01-03
Gravier Pierre
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2025-01-03+22,50076,771 total
  • Award

    Stock Option (Right to Buy)

    2025-01-03+56,25056,250 total
    Exercise: $46.54Exp: 2035-01-02Common Stock (56,250 underlying)
Footnotes (3)
  • [F1]Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026.
  • [F2]Includes 339 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024.
  • [F3]This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001984065

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:20 PM ET
Size
7.7 KB